Cookies

martes, 29 de septiembre de 2015

Novavax Announces Grant of Up to $89 Million to Support Development of RSV F Vaccine to Protect Infants Via Maternal Immunization

Novavax Announces Grant of Up to $89 Million to Support Development of RSV F Vaccine to Protect Infants Via Maternal Immunization

Bill & Melinda Gates Foundation to Support Development of the RSV F Vaccine Program
GAITHERSBURG, Md.Sept. 29, 2015 (GLOBE NEWSWIRE)

No hay comentarios:

Publicar un comentario

Muchas gracias por tu comentario. En cuanto me sea posible te daré mi opinión.